|
GB9806916D0
|
|
Chiral amines
|
|
GB9806284D0
|
|
Asymmetric hydrogenation
|
|
GB9803356D0
|
|
Asymmetric hydrogenation
|
|
GB9803022D0
|
|
Chiral phosphorus-based ligands
|
|
GB9802748D0
|
|
Benzofurans and their therapeutic use
|
|
GB9802618D0
|
|
Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
|
|
GB9802622D0
|
|
Compounds and their therapeutic use
|
|
GB9802620D0
|
|
Hydroxamic and carboxylic acid derivates
|
|
GB9802073D0
|
|
Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
|
|
AU5871998A
|
|
Peptidyl compounds having mmp and tnf inhibitory activity
|
|
WO9907679A1
|
|
Peptidyl compounds having mmp and tnf inhibitory activity
|
|
GB9800645D0
|
|
Assay
|
|
AU5183098A
|
|
Analgesic agent and its use
|
|
GB9726917D0
|
|
Desymmetrisation
|
|
GB9726679D0
|
|
Asymmetric hydrogenation
|
|
GB9725637D0
|
|
Benzofurans and their therapeutic use
|
|
GB9725275D0
|
|
Formulation
|
|
GB9724506D0
|
|
Levobupivacaine and its use
|
|
GB9723905D0
|
|
Heterocyclic compounds having MMP and TNF inhibitory activity
|
|
GB9723906D0
|
|
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activiy
|
